News

That’s a wrap! Our September events have come to an end at ALS Canada, and we can’t help but look back at how the community came out to ride and pull to end ALS. Both the ALS Canada Pull to…

This blog series is a place for the ALS community to learn about and stay updated on ALS Canada’s advocacy efforts as well as relevant developments within government. Please note that because ALS Canada advocates federally and provincially within Ontario,…

Support the ALS cause and raise critical funds for a future without ALS On Sunday, September 24, cyclists will come together to gear up for change at the third annual ALS Canada Revolution Ride in Dundas, Ontario. Participants come together…

The ALS Society of Canada (ALS Canada) and the Kevin Daly Bursary Fund are pleased to announce the recipients of the 2023 ALS Canada Kevin Daly Bursary, granted to post-secondary students who share a personal connection to amyotrophic lateral sclerosis…

Pull to End ALS – a unique fundraiser to support people and families living with ALS On Saturday, September 16, the ALS community will come together to “pull” for change at the ALS Canada Pull to End ALS presented by…

In March 2023, the ALS Society of Canada and Brain Canada announced the latest round of Discovery Grant recipients from their 2022 research grant competition. With support from SLA Québec and the Dr. Jean-Pierre Canuel Fund, nine Canadian researchers and…

In March 2023, the ALS Society of Canada and Brain Canada announced the latest round of Discovery Grant recipients from their 2022 research grant competition. With support from SLA Québec and the Dr. Jean-Pierre Canuel Fund, nine Canadian researchers and…

The province of Ontario has listed RADICAVA Oral Suspension (edaravone), also known as oral edaravone, on the public formulary as a therapy accessible through the Ontario Drug Benefit Program’s Exceptional Access Program (EAP) as a treatment for ALS. This decision…